Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04683731 · ClinicalTrials.gov registry record · NA
Helping Patients and Providers Make Better Decisions About Colorectal Cancer Screening
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 1,111
- Enrollment target
NCT04683731: Completed NA study, sponsored by Indiana University.
NCT04683731 is a NA study that has completed, run by Indiana University. The registered enrollment target is 1,111 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (21% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04683731, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,111 participants
- Enrollment target
Study Summary
Precision prevention holds great promise for colorectal cancer (CRC) screening but has not been adequately explored. A patient's chance of having an advanced colorectal neoplasm (ACN), i.e. a cancer or precancerous polyp in the colon, significantly affects the comparative effectiveness of approved tests. Giving patients a decision aid with information about their risk for ACN, and giving their providers similar information, could help patients and providers decide if colonoscopy or a non-invasive test (such as the fecal immunochemical test) is more appropriate. This could improve decision making and increase uptake of CRC screening, which are the investigative team's long-term goals.
Primary Outcome
Patients' completion of colonoscopy, fecal immunochemical testing (FIT), or other CRC screening within 6 months, based on documentation in the participants' electronic health record.
Interventions
- BEHAVIORAL Decision aid without personalized message
- BEHAVIORAL Decision aid with personalized message
- BEHAVIORAL Provider notification without personalized message
- BEHAVIORAL Provider notification with personalized message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,111 participants |
| Start Date | 2021-01-19 |
| Est. Completion | 2023-07-31 |
| Phase | NA |
What the finished NCT04683731 record still lists
NCT04683731 is an interventional study that assigns participants to a tested intervention. Its 1,111 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (21% lower).
The record links to 0 conditions, and to 4 interventions - of which Decision aid without personalized message is the first listed.
NCT04683731 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04683731 about?
NCT04683731 is a clinical study titled "Helping Patients and Providers Make Better Decisions About Colorectal Cancer Screening". Precision prevention holds great promise for colorectal cancer (CRC) screening but has not been adequately explored. A patient's chance of having an advanced colorectal neoplasm (ACN), i.e. a cancer or precancerous polyp in the colon, significantly affects the comparative effectiveness of approved t...
What is the current status of trial NCT04683731?
This trial is currently completed. It is a NA study. The enrollment target is 1,111 participants. The study started on 2021-01-19. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT04683731?
The interventions under investigation include: Decision aid without personalized message (BEHAVIORAL), Decision aid with personalized message (BEHAVIORAL), Provider notification without personalized message (BEHAVIORAL), Provider notification with personalized message (BEHAVIORAL).
Who is sponsoring clinical trial NCT04683731?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04683731's enrollment target sits among peer trials
1,111 93rd of 2000 higher than 1,908 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- NCT06618534 · 1,120 participants · Phase 2
Azithromycin for Meningococcal Carriage
- NCT07164131 · 1,120 participants · Phase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI